Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr 25;11(2):253-66.
doi: 10.5114/aoms.2015.50960. Epub 2015 Apr 23.

Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials

Affiliations
Free PMC article
Review

Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials

Sorin Ursoniu et al. Arch Med Sci. .
Free PMC article

Abstract

Introduction: Many studies have shown that oral supplementation with astaxanthin may be a novel potential treatment for inflammation and oxidative stress in cardiovascular diseases, but evidence of the effects on lipid profile and glucose is still inconclusive. Therefore, we performed a meta-analysis to evaluate the efficacy of astaxanthin supplementation on plasma lipid and glucose concentrations.

Material and methods: The search included PubMed, Cochrane Library, Scopus, and EMBASE (up to November 27, 2014) to identify randomized controlled trials (RCTs) investigating the effects of astaxanthin supplementation on lipid profile and glucose levels. Two independent reviewers extracted data on study characteristics, methods and outcomes.

Results: Seven studies meeting inclusion criteria with 280 participants were selected for this meta-analysis; 163 participants were allocated to the astaxanthin supplementation group and 117 to the control group. A random-effect meta-analysis of data from 7 RCTs (10 treatment arms) did not show any significant effect of supplementation with astaxanthin on plasma concentrations of total cholesterol (weighted mean difference (WMD): -1.52 mg/dl, 95% CI: -8.69 to -5.66, p = 0.679), LDL-C (WMD: +1.25 mg/dl, 95% CI: -6.70 to +9.21, p = 0.758), HDL-C (WMD: +1.75 mg/dl, 95% CI: -0.92 to +4.42, p = 0.199), triglycerides (WMD: -4.76 mg/dl, 95% CI: -21.52 to +12.00, p = 0.578), or glucose (WMD: -2.65 mg/dl, 95% CI: -5.84 to +0.54, p = 0.103). All these effect sizes were robust, and omission of any of the included studies did not significantly change the overall estimate.

Conclusions: This meta-analysis of data from 10 RCT arms did not indicate a significant effect of supplementation with astaxanthin on plasma lipid profile, but a slight glucose-lowering effect was observed. Further, well-designed trials are necessary to validate these results.

Keywords: antioxidants; astaxanthin; glucose; lipids.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of the study selection procedure showing the number of eligible randomized controlled trials for the meta-analysis of the impact of astaxanthin supplementation on plasma lipid concentrations
Figure 2
Figure 2
Plots showing the risk of bias of the included trials according to Cochrane quality assessment tool
Figure 3
Figure 3
Forest plot detailing weighted mean difference and 95% confidence intervals for the impact of astaxanthin supplementation on plasma total cholesterol concentrations (upper graph). Leave-one-out sensitivity analysis is shown in the lower graph
Figure 4
Figure 4
Forest plot detailing weighted mean difference and 95% confidence intervals for the impact of astaxanthin supplementation on plasma LDL-C concentrations. Leave-one-out sensitivity analysis is shown in the lower graph
Figure 5
Figure 5
Forest plot detailing weighted mean difference and 95% confidence intervals for the impact of astaxanthin supplementation on plasma HDL-C concentrations. Leave-one-out sensitivity analysis is shown in the lower graph
Figure 6
Figure 6
Forest plot detailing weighted mean difference and 95% confidence intervals for the impact of astaxanthin supplementation on plasma triglyceride concentrations. Leave-one-out sensitivity analysis is shown in the lower graph
Figure 7
Figure 7
Forest plot detailing weighted mean difference and 95% confidence intervals for the impact of astaxanthin supplementation on plasma glucose concentrations. Leave-one-out sensitivity analysis is shown in the lower graph
Figure 8
Figure 8
Meta-regression plots of the association between mean changes in plasma lipids and glucose concentrations and administered astaxanthin dose. The size of each circle is inversely proportional to the variance of change.
Figure 9
Figure 9
Funnel plots detailing publication bias in the studies selected for analysis. Trim and fill method was used to impute for potentially missing studies. Open circles represent observed published studies; closed circles represent imputed unpublished studies

Similar articles

Cited by

References

    1. Zhao ZW, Cai W, Lin YL, et al. Ameliorative effect of astaxanthin on endothelial dysfunction in streptozotocin-induced diabetes in male rats. Arzneimittel-Forschung. 2011;61:239–46. - PubMed
    1. Boussiba S, Cohen Z, Richmond A, Vonshak A. Procedure for large-scale production of astaxanthin from Haematococcus; Google Patents; 2000.
    1. Choi HD, Kang HE, Yang SH, Lee MG, Shin WG. Pharmacokinetics and first-pass metabolism of astaxanthin in rats. Br J Nutrition. 2011;105:220–7. - PubMed
    1. Aoi W, Naito Y, Takanami Y, et al. Astaxanthin improves muscle lipid metabolism in exercise via inhibitory effect of oxidative CPT I modification. Biochem Biophys Res Comm. 2008;366:892–7. - PubMed
    1. Derosa G, Limas CP, Macías PC, Estrella A, Maffioli P. Dietary and nutraceutical approach to type 2 diabetes. Arch Med Sci. 2014;10:336. - PMC - PubMed

LinkOut - more resources